Vanderbilt University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Vanderbilt University sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).

430 total trials 15 currently recruiting 343 completed early-phase tilt top decile by trial count

Vanderbilt University: 430 sponsored US clinical trials, 15 recruiting.

Vanderbilt University sponsors 430 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 343 completed. 42 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.

Top-decile sponsor footprint

Vanderbilt University ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 53/100

343 of 401 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

430 total, page 5 of 9

COMPLETED NA

Smoking Cessation Invention in the Emergency Department (ED)

NCT01173653
COMPLETED Phase 1

Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis

NCT01169038
COMPLETED

The Fibrosis-Lymphedema Continuum in Head and Neck Cancer

NCT01187173
TERMINATED NA

Topical Silver for Prevention of Wound Infection After Cesarean Delivery

NCT01169064
COMPLETED

Atrial Fibrillation/Flutter Outcome Risk Determination

NCT01138644
COMPLETED NA

Can a Brief Primary Care Intervention Affect Healthy Weight Habits

NCT01533896
COMPLETED NA

The Effect of Primary Care Interventions on Children's Media Viewing Habits and Exposure to Violence

NCT01490320
COMPLETED Phase 1

A Brief Multimedia Program Affects Parents' Attitudes Toward Physical Punishment

NCT01459510
COMPLETED NA

Achieving Medication Safety During Acute Kidney Injury

NCT01134900
COMPLETED Phase 1

Autonomic Nervous System and Nitric Oxide Interactions

NCT01137253
TERMINATED

Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use

NCT00968721
COMPLETED NA

Online Resources to Manage Obesity and Health Risks in an Employee Wellness Program

NCT01122420
COMPLETED

A Comparison of Skin Prick Tests, Clinical Symptoms, and Nasal Challenge Using a New Mouse Extract

NCT01063985
COMPLETED NA

Addressing Health Literacy and Numeracy to Prevent Childhood Obesity

NCT01040897
COMPLETED NA

Pain Relief at Iliac Crest Bone Harvest Sites in Spine Surgery Using Bupivacaine

NCT01087931
COMPLETED

Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients

NCT01228461
COMPLETED Phase 1

Trial of Antimycobacterial Therapy in Sarcoidosis

NCT01074554
COMPLETED NA

Conventional vs Mindfulness Intervention in Parents of Children With Disabilities

NCT01110343
TERMINATED

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

NCT01077440
COMPLETED NA

Nebivolol in the Supine Hypertension of Autonomic Failure

NCT01044693
COMPLETED Early Phase 1

Study Using Citrate to Replace Heparin in Babies Requiring Extracorporeal Membrane Oxygenation (ECMO)

NCT00968565
TERMINATED NA

A Gastrointestinal Quality of Life Study in Lung Transplant Recipients Converted From Mycophenolate Mofetil to Myfortic

NCT01044667
TERMINATED Phase 3

Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3

NCT00878969
COMPLETED

Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer

NCT01098669
COMPLETED Phase 1

Intravitreal Ketorolac for Chronic Uveitis: A Investigational Safety Study

NCT01164085
COMPLETED

Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer

NCT01096394
COMPLETED Phase 1

Deep Brain Stimulation (DBS) Frequency Effects on Gait in Parkinson's Disease(PD)

NCT00993291
COMPLETED Phase 2

Reduced Calorie Diet Intervention in Kidney Transplant Recipients

NCT00994838
TERMINATED Phase 3

Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits

NCT01000064
TERMINATED NA

Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors

NCT01098643
COMPLETED NA

Working on Rapid Language Development in Toddlers

NCT01975922
COMPLETED Phase 4

The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans

NCT00872599
COMPLETED Phase 4

Low Level Laser Treatment and Breast Cancer Related Lymphedema

NCT00852930
COMPLETED

Chest Wall Repair of Rib Fractures After Trauma

NCT00926991
COMPLETED Phase 2

RECAP Multi-Component Intervention Program

NCT01488292
COMPLETED NA

Situational Problem Solving in Adolescents With Type 2 Diabetes: Enhancing a Randomized Controlled Trial (RCT)

NCT00889785
COMPLETED NA

Home-based Compression Therapy for Arm and Truncal Lymphedema in Breast Cancer

NCT00880022
COMPLETED NA

Inflammation and Insulin Resistance in Rheumatoid Arthritis

NCT00763139
COMPLETED

Effects Rapid Atrial Pacing Has on the Electrocardiogram (ECG) in Patients With Dual Chamber Pacemakers

NCT00883610
TERMINATED

Uncemented Total Elbow Arthroplasty Data Collection

NCT00974298
COMPLETED

Muscle Ultrasound: A New Tool for Measuring Progression in Amyotrophic Lateral Sclerosis (ALS)

NCT00838617
COMPLETED

Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics

NCT00831961
COMPLETED

Neurophysiology and Anatomy of Severe Intraventricular Hemorrhage (IVH)

NCT00817310
COMPLETED NA

Interactions Between Physical Activity and Cannabis Use in Adults

NCT00838448
COMPLETED NA

Variability in Adrenergic Response

NCT00838695
COMPLETED

Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings

NCT00897078
COMPLETED Phase 4

Is Levocetirizine Less Sedating Than Cetirizine?

NCT00826943
COMPLETED NA

Genetic Determinants of Response to Beta Blockade

NCT00837902
COMPLETED

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

NCT00993694
COMPLETED NA

Dopamine and Insulin Resistance

NCT00802204
← Previous Page 5 of 9 Next →

Phase Distribution

PhaseTrial count
Phase 1 50
Phase 2 42
Phase 3 10
Phase 4 32

Therapeutic Areas

Obesity 8
Hypertension 7
Atrial Fibrillation 5
End Stage Renal Disease 4
Postural Tachycardia Syndrome 3
Reading Disability 3
Type 2 Diabetes 3
Critical Illness 3
Depression 3
Autism Spectrum Disorder 3

What is open in the Vanderbilt University pipeline

15 recruiting of 430 indexed (3% open); 343 completed (80%).

Phase mix: 42 late (III/IV) vs 92 early (I/II) (early-phase heavy).

Top condition: Obesity (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vanderbilt University: open-pipeline peers nationwide

Peers matched on 430 registered trials and 3% open enrollment, not the therapeutic-area sidebar.

Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 0%10%20%30% Total trials Recruiting share Vanderbilt UniversityUniversity of Illinois at ChicagoChildren's Hospital of PhiladelphiaNovo Nordisk A/SDartmouth-Hitchcock Medical CenterUSDA Grand Forks Human Nutrition Research CenterMedtronic MiniMedSandozSonova
Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 430 trials (± recruiting share)

Sponsors near 3% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Vanderbilt University page

430 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University or any single study.

  • 15 of Vanderbilt University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Vanderbilt University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Vanderbilt University pipeline card: 430 registered trials from official public datasets.Report a data error.